494
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluation

Adalimumab for rheumatoid arthritis

&
Pages 1349-1360 | Published online: 22 Nov 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Eleftherios Pelechas, Paraskevi V. Voulgari & Alexandros A. Drosos. (2018) ABP 501 for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 18:3, pages 317-322.
Read now
Paraskevi V Voulgari & Alexandros A Drosos. (2014) Adalimumab in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 14:4, pages 549-561.
Read now
Paraskevi V Voulgari, Evripidis Kaltsonoudis, Charalampos Papagoras & Alexandros A Drosos. (2012) Adalimumab in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 12:12, pages 1679-1686.
Read now
Charalampos Papagoras, Paraskevi V Voulgari & Alexandros A Drosos. (2009) Long-term use of adalimumab in the treatment of rheumatic diseases. Open Access Rheumatology: Research and Reviews 1, pages 51-68.
Read now
Mahendra P Deonarain. (2008) Recombinant antibodies for cancer therapy. Expert Opinion on Biological Therapy 8:8, pages 1123-1141.
Read now
Katerina Antoniou, Michael Malamas & Alexandros A Drosos. (2007) Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Expert Opinion on Pharmacotherapy 8:11, pages 1719-1732.
Read now

Articles from other publishers (15)

Yijia Jiang, Taruna Arora, Scott Klakamp, Janice Davis, Yasmin A. Chandrasekher, Glen Young, Yue Du, Bin Yu & Karen J. Miller. (2023) Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab. Drugs in R&D 23:4, pages 377-395.
Crossref
Prerna Sharma, Rahul V. Joshi, Robert Pritchard, Kevin Xu & Maya A. Eicher. (2023) Therapeutic Antibodies in Medicine. Molecules 28:18, pages 6438.
Crossref
Chenyu ZhangPeixiang MaAn QinLiao WangKerong DaiYuanyuan LiuJie ZhaoZuyan Lu. (2023) Current Immunotherapy Strategies for Rheumatoid Arthritis: The Immunoengineering and Delivery Systems. Research 6.
Crossref
Peeyush Prasad, Sneha Verma, Surbhi, Nirmal Kumar Ganguly, Ved Chaturvedi & Shivani Arora Mittal. (2022) Rheumatoid arthritis: advances in treatment strategies. Molecular and Cellular Biochemistry 478:1, pages 69-88.
Crossref
Anna-Lena Mueller, Zahra Payandeh, Niloufar Mohammadkhani, Shaden M. H. Mubarak, Alireza Zakeri, Armina Alagheband Bahrami, Aranka Brockmueller & Mehdi Shakibaei. (2021) Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 10:11, pages 3017.
Crossref
Mona Sadeghalvad & Nima Rezaei. 2021. Monoclonal Antibodies. Monoclonal Antibodies.
Priya Nijhawan & Tapan Behl. (2021) The Role of Endostatin in Rheumatoid Arthritis. Current Rheumatology Reviews 17:1, pages 68-75.
Crossref
Melissa Joyce SamSusan Jane Connor, Watson Wa-Sang Ng & Catherine Mei-Ling Toong. (2020) Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies. Therapeutic Drug Monitoring 42:6, pages 821-828.
Crossref
Mojtaba Abbasi, Mohammad Javad Mousavi, Sirous Jamalzehi, Reza Alimohammadi, Maryam Hasanzadeh Bezvan, Hamed Mohammadi & Saeed Aslani. (2018) Strategies toward rheumatoid arthritis therapy; the old and the new. Journal of Cellular Physiology 234:7, pages 10018-10031.
Crossref
Taketo Yamada. (2011) Therapeutic Monoclonal Antibodies. The Keio Journal of Medicine 60:2, pages 37-46.
Crossref
Olaf Schultz, Frank Oberhauser, Jasemine Saech, Andrea Rubbert-Roth, Moritz Hahn, Wilhelm Krone & Matthias Laudes. (2010) Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases. PLoS ONE 5:12, pages e14328.
Crossref
Huseyin TE Ozer & Zeynep Ozbalkan. (2010) Clinical efficacy of TNF-α inhibitors: an update. International Journal of Clinical Rheumatology 5:1, pages 101-115.
Crossref
Ningyan Zhang, Brent R. Williams, Ping Lu, Zhiqiang An & Chen-Ni Chin. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies 711 762 .
Marcia L Moss, Liora Sklair-Tavron & Raphael Nudelman. (2008) Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nature Clinical Practice Rheumatology 4:6, pages 300-309.
Crossref
Frank Mielke & Marcus Schweigert. (2008) Safe adalimumab therapy for rheumatoid arthritis in a patient with pre-existing multiple myeloma. Nature Clinical Practice Rheumatology 4:4, pages 218-221.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.